Top Stories
Aletta handles most of the blood-draw procedure itself, starting with finding a vein to changing tubes and finishing by placing a bandage.
The startup already has a $30-million-plus co-development and licensing deal with a Fortune 100 healthcare company and is working with NVIDIA to scale its medical AI models.
ENV-308 was designed to mimic the appetite-suppressing effect of a natural hormone released post-exercise, called Lac-Phe.
The agency is seeking input from the public on risk assessment, premarket evaluation and postmarket monitoring for the "transformative" devices.
The virtual cell world model is the first AI system to integrate the entire molecular-to-cellular spectrum into one continuous simulation.
Conference News
Real-world evidence on NSCLC treatment patterns and outcomes showcases Flatiron's unified, global oncology engineNEW YORK--(BUSINESS WIRE)-- Flatiron Health today announced its presence at the IASLC 2...
DALLAS, Aug. 18, 2026 — Despite rapid advances in digital health, artificial intelligence and remote patient monitoring, many promising health technologies still fail to reach patients who need them m...
First randomized controlled trial of an at-home, noninvasive BCI therapy for chronic stroke shows more than half of patients achieved clinically meaningful recoveryVAN NUYS, Calif., Aug. 18, 2026 /PRN...
Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry's first multi-agent Virtual Aging Cell (VAC) platform with biologica...
SAN FRANCISCO--(BUSINESS WIRE)-- Astro Health Inc., a San Francisco-based artificial intelligence digital health company, today announced that its first peer-reviewed research from its clinical study ...



